Back to Search Start Over

P522 Efficacy and safety of adalimumab 80 mg weekly in Crohn's disease.

Authors :
Bouguen, G.
Laharie, D.
Nancey, S.
Hébuterne, X.
Flourié, B.
Filippi, J.
Roblin, X.
Trang, C.
Boureille, A.
Babouri, A.
Bretagne, J.-F.
Siproudhis, L.
Peyrin-Biroulet, L.
Source :
Journal of Crohn's & Colitis; Feb2013 Supplement, Vol. 7, pS219-S219, 1p
Publication Year :
2013

Details

Language :
English
ISSN :
18739946
Volume :
7
Database :
Supplemental Index
Journal :
Journal of Crohn's & Colitis
Publication Type :
Academic Journal
Accession number :
85616699
Full Text :
https://doi.org/10.1016/S1873-9946(13)60543-7